Dr. Marks will discuss the work of this important FDA center, which is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies.
A virtual meeting of PMC's Public and Science Policy Committees will take place via Zoom on April 24, 2024, from 12:00 - 2:00 p.m. ET. PMC members will receive details and a registration link via email.
This summit will seek solutions to the specific economic gaps limiting the advancement of precision medicine. PMC Senior Vice President for Science Policy Daryl Pritchard will contribute to the discussions. Learn more at https://www.diaceutics.com/articles/multi-stakeholder-group-bring-a-unique-economic-solution-to-the-clinical-practice-gaps-holding-back-precision-medicine.
The Future of Biotechnology in Individualized Medicine Conference will explore the ongoing evolution of genomics from a tool for diagnostic breakthroughs to a driver of revolutionary therapeutics. Learn more at https://web.cvent.com/event/5ffdb74b-03b3-4ba9-ac99-7acde7751e61/websitePage:80210dd7-0a79-40ca-aedc-fb8b1fb6c56e.
During the Personalized Medicine Coalition's 16th Annual State of Personalized Medicine Luncheon, U.S. National Institutes of Health Director Monica Bertagnolli outlined her thoughts on the future of biomedical research and personalized medicine.
A virtual meeting of PMC's Public and Science Policy Committees will take place via Zoom on June 25, 2024, from 12:00 - 2:00 p.m. ET. PMC members will receive details and a registration link via email.
This hybrid workshop will examine how researchers could more meaningfully engage and sustain interactions with historically underrepresented communities in research to foster their participation in genomics and precision health studies. Learn more at https://www.nationalacademies.org/event/42785_07-2024_sustaining-community-engagement-in-genomics-research-a-workshop.
The 2024 Next Generation Dx Summit will explore trends in point-of-care and decentralized testing, infectious disease, liquid biopsy, multi-cancer early detection, reimbursement, regulation, and companion diagnostics to improve the standard of care in medicine. Learn more at https://www.nextgenerationdx.com/.
The Individualizing Medicine Conference is dedicated to unraveling the intricacies of population -omics, digital -omics, functional -omics, and rare disease -omics, and their vital role in patient care. Learn more at https://individualizingmedicineconference.mayo.edu/.
McDermott+Consulting organizes the +Dx Diagnostics Forum to provide members of the laboratory diagnostics community with key insights from industry innovators, thought leaders, regulators, and decision-makers. The forum covers the regulatory, legislative, and market developments shaping the future of the diagnostics space.
A virtual meeting of PMC's Public and Science Policy Committees will take place via Zoom on September 25, 2024, from 12:00 - 2:00 p.m. ET. PMC members will receive details and a registration link via email.
This webinar will provide an overview of recent research conducted by the National Pharmaceutical Council and Johnson & Johnson, followed by a panel discussion with patient group experts to address important questions related to the U.S. Food and Drug Administration's Accelerated Approval program.
Blog
Read the latest
Resources
Download publications
Personalized Medicine Coalition
1710 Rhode Island Ave. NW
Suite 700
Washington, DC 20036
202-589-1770
pmc@personalizedmedicinecoalition.org
© 2024 Personalized Medicine Coalition. All rights reserved. | Privacy Policy
